Agios Pharmaceuticals, Inc. (AGIO) Operating income 2016–2025
Agios Pharmaceuticals, Inc. (AGIO) annual operating income history from SEC filings — each fiscal year as reported.
-$472.1MFY2025 · since FY2016: -$201.0M → -$472.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$472.1M | -10.9% |
| FY2024 | -$425.7M | -8.7% |
| FY2023 | -$391.5M | -0.6% |
| FY2022 | -$389.0M | -2.8% |
| FY2021 | -$378.4M | -12.7% |
| FY2020 | -$335.9M | -6.2% |
| FY2019 | -$316.3M | +12.7% |
| FY2018 | -$362.5M | -13.0% |
| FY2017 | -$320.8M | -59.6% |
| FY2016 | -$201.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice